Using Restricted Mean Survival Time to Improve Interpretability of Time-to-Event Data Analysis

被引：9

作者：

Charu, Vivek ^{[1
,2
]}

Tian, Lu ^{[3
]}

Tamura, Manjula Kurella ^{[4
,5
]}

Montez-Rath, Maria E. ^{[5
,6
]}

机构：

[1] Stanford Univ, Sch Med, Dept Med, Quantitat Sci Unit, Stanford, CA USA

[2] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA USA

[3] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA USA

[4] VA Palo Alto Hlth Care Syst, Geriatr Res & Educ Clin Ctr, Palo Alto, CA USA

[5] Stanford Univ, Sch Med, Dept Med, Div Nephrol, Stanford, CA USA

[6] Stanford Univ, Dept Med, Div Nephrol, Sch Med, 3180 Porter Dr, Palo Alto, CA 94304 USA

来源：

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 19卷 / 02期

关键词：

clinical epidemiology; epidemiology and outcomes; nephrology; survival;

D O I：

10.2215/CJN.0000000000000323

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：260 / 262

页数：3

共 10 条

[1] KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease Abstracts [J].

不详 .

KIDNEY INTERNATIONAL, 2021, 99 (03) :S26-S87

[2] Causal inference on the difference of the restricted mean lifetime between two groups [J].

Chen, PY ;

Tsiatis, AA .

BIOMETRICS, 2001, 57 (04) :1030-1038

[3] The Hazards of Hazard Ratios [J].

Hernan, Miguel A. .

EPIDEMIOLOGY, 2010, 21 (01) :13-15

[4] Uses and Limitations of the Restricted Mean Survival Time: Illustrative Examples From Cardiovascular Outcomes and Mortality Trials in Type 2 Diabetes [J].

Kloecker, David E. ;

Davies, Melanie J. ;

Khunti, Kamlesh ;

Zaccardi, Francesco .

ANNALS OF INTERNAL MEDICINE, 2020, 172 (08) :541-+

[5] Final Report of a Trial of Intensive versus Standard Blood-Pressure Control [J].

Lewis, Cora E. ;

Fine, Lawrence J. ;

Beddhu, Srinivasan ;

Cheung, Alfred K. ;

Cushman, William C. ;

Cutler, Jeffrey A. ;

Evans, Gregory W. ;

Johnson, Karen C. ;

Kitzman, Dalane W. ;

Oparil, Suzanne ;

Rahman, Mahboob ;

Reboussin, David M. ;

Rocco, Michael V. ;

Sink, Kaycee M. ;

Snyder, Joni K. ;

Whelton, Paul K. ;

Williamson, Jeff D. ;

Wright, Jackson T., Jr. ;

Ambrosius, Walter T. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (20) :1921-1930

[6] Subtleties in the interpretation of hazard contrasts [J].

Martinussen, Torben ;

Vansteelandt, Stijn ;

Andersen, Per Kragh .

LIFETIME DATA ANALYSIS, 2020, 26 (04) :833-855

[7] Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome [J].

Royston, Patrick ;

Parmar, Mahesh K. B. .

BMC MEDICAL RESEARCH METHODOLOGY, 2013, 13

[8] On the empirical choice of the time window for restricted mean survival time [J].

Tian, Lu ;

Jin, Hua ;

Uno, Hajime ;

Lu, Ying ;

Huang, Bo ;

Anderson, Keaven M. ;

Wei, L. J. .

BIOMETRICS, 2020, 76 (04) :1157-1166

[9] Predicting the restricted mean event time with the subject's baseline covariates in survival analysis [J].

Tian, Lu ;

Zhao, Lihui ;

Wei, L. J. .

BIOSTATISTICS, 2014, 15 (02) :222-233

[10] Evidence-Based Risk Communication A Systematic Review [J].

Zipkin, Daniella A. ;

Umscheid, Craig A. ;

Keating, Nancy L. ;

Allen, Elizabeth ;

Aung, Koko ;

Beyth, Rebecca ;

Kaatz, Scott ;

Mann, Devin M. ;

Sussman, Jeremy B. ;

Korenstein, Deborah ;

Schardt, Connie ;

Nagi, Avishek ;

Sloane, Richard ;

Feldstein, David A. .

ANNALS OF INTERNAL MEDICINE, 2014, 161 (04) :270-+

← 1 →